Free Sample — Artis BioSolutions
Limited Offer  ·  First 50 Qualified Requests

Try Pure Synthetic oDNA.
Free.

No bacterial backbone. No antibiotic resistance genes. No cloning steps. Request a free research sample of Syngoi's Pure Synthetic oDNA — produced enzymatically, completely cell-free and plasmid-free.

Request Your Free Sample artisbiosolutions.com/free-sample  ·  Ships from Boston in 1–2 weeks
Why oDNA outperforms plasmid DNA

A better DNA template changes everything downstream.

Plasmid-based DNA production has been the default for decades. But bacterial cloning introduces impurities, antibiotic resistance genes, and structural variability that compound through every downstream step.

Syngoi's Pure Synthetic oDNA takes a different approach: a fully enzymatic, cell-free process that produces DNA from µg scale to hundreds of mgs — completely plasmid-free, with no cloning steps, no bacterial backbone, and no antibiotic resistance genes.

60%
Improvement in IVT mRNA yield vs. plasmid DNA
30%
Reduction in cost per dose
2wk
Turnaround for RUO and GMP-compliant material
US & EU
Dual-site supply with de-risked, global access
PolyA compatibility
Compatible with sequences bearing PolyA tails, including complex polyadenylation signals. Removes a major limitation of plasmid-based templates.
Customizable adaptor library
Proprietary adaptor combinations allow DNA to be tailored for gene therapy, gene editing, CAR-T, non-viral delivery, mRNA, AAVs, and lentivirus applications.
From RUO to GMP
Research-grade samples available now. US-based RUO manufacturing starts April 2026. GMP-compliant supply in development at Landmark Bio, Watertown, MA.
US-based supply chain
Manufactured at Landmark Bio's 44,000 sq ft facility in Watertown, MA. Shorter lead times, stronger supply chain resilience for North American programs.
Brought to you by
Artis BioSolutions
Syngoi Technologies

Request Your Free Sample

Complete the form below. Our team will review your request and confirm within 48 hours.

17 of 50 samples claimed

By submitting this form you agree to be contacted by Artis BioSolutions regarding your request. We will not share your information with third parties. Review our privacy policy.

Press Release  ·  March 2026

Artis BioSolutions Establishes US-Based Synthetic DNA Manufacturing Hub in Boston

Syngoi Technologies' enzymatic platform is now integrated into Artis' North American operations at Landmark Bio, Watertown, MA.

Read the full press release